These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35416563)

  • 1. N-type calcium channel and renal injury.
    Bai L; Sun S; Sun Y; Wang F; Nishiyama A
    Int Urol Nephrol; 2022 Nov; 54(11):2871-2879. PubMed ID: 35416563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-/N-type calcium channel blockers and proteinuria.
    Ando K
    Curr Hypertens Rev; 2013 Aug; 9(3):210-8. PubMed ID: 24479751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal microcirculation and calcium channel subtypes.
    Homma K; Hayashi K; Yamaguchi S; Fujishima S; Hori S; Itoh H
    Curr Hypertens Rev; 2013 Aug; 9(3):182-6. PubMed ID: 24479750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition.
    Lei B; Nakano D; Fujisawa Y; Liu Y; Hitomi H; Kobori H; Mori H; Masaki T; Asanuma K; Tomino Y; Nishiyama A
    J Pharmacol Sci; 2012; 119(4):359-67. PubMed ID: 22863666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels.
    Hansen PB
    Acta Physiol (Oxf); 2013 Apr; 207(4):690-9. PubMed ID: 23351056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N- and L-type calcium channels in depolarization-induced activation of tyrosine hydroxylase and release of norepinephrine by sympathetic cell bodies and nerve terminals.
    Rittenhouse AR; Zigmond RE
    J Neurobiol; 1999 Aug; 40(2):137-48. PubMed ID: 10413445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channels involved in noradrenaline release from sympathetic neurones in rabbit carotid artery.
    Uhrenholt TR; Nedergaard OA
    Pharmacol Toxicol; 2003 May; 92(5):226-33. PubMed ID: 12753410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New calcium channel blockers for the treatment of hypertension].
    Tamargo J
    Hipertens Riesgo Vasc; 2017; 34 Suppl 2():5-8. PubMed ID: 29908667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic view of renal protective action of calcium channel blockade.
    Sugano N; Hayashi K; Hosoya T; Yokoo T
    Curr Hypertens Rev; 2013 Aug; 9(3):187-92. PubMed ID: 24749517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine reduces ω-conotoxin-sensitive Ca2+ currents in renal afferent neurons in rats.
    Ditting T; Linz P; Freisinger W; Heinlein S; Reeh PW; Fiedler C; Siegel K; Scrogin KE; Neuhuber W; Veelken R
    Am J Physiol Renal Physiol; 2012 Feb; 302(3):F350-7. PubMed ID: 22049399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.
    Konda T; Enomoto A; Takahara A; Yamamoto H
    Biol Pharm Bull; 2006 May; 29(5):933-7. PubMed ID: 16651722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP and PACAP inhibit L-, N- and P/Q-type Ca2+ channels of parasympathetic neurons in a voltage independent manner.
    Hayashi K; Endoh T; Shibukawa Y; Yamamoto T; Suzuki T
    Bull Tokyo Dent Coll; 2002 Feb; 43(1):31-9. PubMed ID: 12013823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal protective action of T-, L-, and N-type Ca channel blockers].
    Hayashi K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():654-61. PubMed ID: 15171451
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature.
    Hansen PB; Poulsen CB; Walter S; Marcussen N; Cribbs LL; Skøtt O; Jensen BL
    Hypertension; 2011 Sep; 58(3):464-70. PubMed ID: 21788606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels.
    Hansen PB; Jensen BL; Andreasen D; Skøtt O
    Circ Res; 2001 Sep; 89(7):630-8. PubMed ID: 11577029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury.
    Agrawal SK; Nashmi R; Fehlings MG
    Neuroscience; 2000; 99(1):179-88. PubMed ID: 10924962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.